PatientsEngage supports a Journey of Hope, a seminar highlighting new directions in Cancer Care. Find out how new therapy areas like nuclear medicine therapy and targeted radiotherapy are useful for treating prostate, neuroendocrine and potentially other cancers. Also learn about the role of patient groups in supporting patient and caregiver journeys.
Join us on Sat 5 Nov at Academia Bldg, Singapore General Hospital Campus, or via YouTube
Register here to get the links: https://…
The U.S. Food and Drug Administration approved Cologuard, the first stool-based colorectal screening test that detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths that may be cancers such as colon cancer or precursors to cancer. Cologuard offers people 50 and older at average risk for colorectal cancer an easy-to-use screening test they can do in the privacy of their own home.
Colorectal cancer was the third most common cancer with nearly 1.4 million new cases in 2012.
http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm409021.htm
Community
Condition
Changed
Fri, 09/12/2014 - 15:09
